Report Detail

According to our (Global Info Research) latest study, the global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
This report is a detailed and comprehensive analysis for global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Jiuyuan Gene Engineering, Cellumed, Yantai Zhenghai Bio-Tech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sponge Carrier
Hydroxyapatite Carrier
Market segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Major players covered
Medtronic
Jiuyuan Gene Engineering
Cellumed
Yantai Zhenghai Bio-Tech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), with price, sales quantity, revenue, and global market share of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) from 2020 to 2025.
Chapter 3, the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2).
Chapter 14 and 15, to describe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Sponge Carrier
    • 1.3.3 Hydroxyapatite Carrier
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Spinal Fusion
    • 1.4.3 Trauma Surgery
    • 1.4.4 Oral Maxillofacial Surgery
    • 1.4.5 Reconstructive
  • 1.5 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size & Forecast
    • 1.5.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity (2020-2031)
    • 1.5.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product and Services
    • 2.1.4 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Jiuyuan Gene Engineering
    • 2.2.1 Jiuyuan Gene Engineering Details
    • 2.2.2 Jiuyuan Gene Engineering Major Business
    • 2.2.3 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product and Services
    • 2.2.4 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Jiuyuan Gene Engineering Recent Developments/Updates
  • 2.3 Cellumed
    • 2.3.1 Cellumed Details
    • 2.3.2 Cellumed Major Business
    • 2.3.3 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product and Services
    • 2.3.4 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cellumed Recent Developments/Updates
  • 2.4 Yantai Zhenghai Bio-Tech
    • 2.4.1 Yantai Zhenghai Bio-Tech Details
    • 2.4.2 Yantai Zhenghai Bio-Tech Major Business
    • 2.4.3 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product and Services
    • 2.4.4 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Yantai Zhenghai Bio-Tech Recent Developments/Updates

3 Competitive Environment: Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) by Manufacturer

  • 3.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturer Market Share in 2024
  • 3.5 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market: Region Footprint
    • 3.5.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market: Company Product Type Footprint
    • 3.5.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Region
    • 4.1.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Region (2020-2031)
  • 4.2 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020-2031)
  • 4.3 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020-2031)
  • 4.5 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 5.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Type (2020-2031)
  • 5.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 6.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Application (2020-2031)
  • 6.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 7.2 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 7.3 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Country
    • 7.3.1 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Country
    • 8.3.1 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 10.2 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 10.3 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Country
    • 10.3.1 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Drivers
  • 12.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Restraints
  • 12.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)
  • 13.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Typical Distributors
  • 14.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2). Industry analysis & Market Report on Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a syndicated market report, published as Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report